What is the treatment for Irritable Bowel Syndrome (IBS) diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for IBS with Diarrhea

Start with loperamide (2-4 mg up to four times daily) for diarrhea control, and if symptoms persist after 4-12 weeks, add a low-dose tricyclic antidepressant (amitriptyline 10 mg at bedtime, titrating to 30-50 mg) for global symptom improvement and abdominal pain relief. 1, 2

First-Line Approach: Lifestyle and Dietary Modifications

  • Recommend regular physical exercise to all patients with IBS-D as this improves global symptoms and should be the foundation of treatment. 1, 2

  • Provide first-line dietary advice including adequate hydration and identifying potential trigger foods (lactose, fructose, sorbitol, gas-producing foods, excessive caffeine). 1, 2

  • Start soluble fiber (ispaghula/psyllium) at 3-4 g/day, building up gradually to avoid bloating, which is effective for both global symptoms and abdominal pain. 1, 2 Critically, avoid insoluble fiber (wheat bran) as it consistently worsens IBS-D symptoms. 1, 2

  • If simple dietary measures fail after 4-6 weeks, consider a low FODMAP diet as second-line dietary therapy, but this must be supervised by a trained dietitian with planned reintroduction of foods according to tolerance. 1

  • Do not recommend food elimination diets based on IgG antibodies as they lack evidence and may lead to unnecessary dietary restrictions. 1, 2

  • Consider a 12-week trial of probiotics for global symptoms and abdominal pain, though no specific strain can be recommended; discontinue if no improvement occurs. 1, 2

First-Line Pharmacological Treatment for Diarrhea Control

  • Loperamide is the first-line pharmacological agent for reducing stool frequency, urgency, and improving consistency in IBS-D. 1, 2 Start at 2-4 mg up to four times daily, titrating carefully to avoid side effects including abdominal pain, bloating, nausea, and constipation. 1, 2

  • Antispasmodics with anticholinergic properties (such as dicyclomine) can be effective for abdominal pain and global symptoms, particularly when symptoms are exacerbated by meals. 1, 2 Common side effects include dry mouth, visual disturbance, and dizziness. 1

  • Peppermint oil is an effective antispasmodic option for abdominal pain with a favorable side effect profile. 3

Second-Line Pharmacological Treatment for Persistent Symptoms

  • Tricyclic antidepressants (TCAs) are the most effective second-line drug for global symptoms and abdominal pain in IBS-D. 1, 2, 4 Start amitriptyline at 10 mg once daily at bedtime and titrate slowly to a maximum of 30-50 mg once daily. 1, 2 Careful explanation of the rationale for their use as gut-brain neuromodulators is required, emphasizing they are not being prescribed for depression. 1

  • Continue TCAs for at least 6 months if the patient reports symptomatic response, then reassess. 3

  • Selective serotonin reuptake inhibitors (SSRIs) may be considered as an alternative second-line neuromodulator for global symptoms when TCAs are not tolerated, though evidence is weaker. 1

Third-Line Treatment Options

  • Rifaximin (550 mg three times daily for 14 days) is FDA-approved for IBS-D and is effective for improving global symptoms, abdominal pain, and stool consistency. 5, 6, 4 It has the most favorable safety profile among approved agents and can be repeated if symptoms recur. 6, 7

  • 5-HT3 receptor antagonists (such as alosetron) are effective for severe IBS-D, particularly in women, but carry a risk of ischemic colitis and severe constipation, limiting their use. 1, 6, 7

  • Eluxadoline (a mixed opioid receptor drug) is an efficacious option for IBS-D but has limited international availability. 1, 6, 7

Special Considerations

  • In patients with prior cholecystectomy or nocturnal diarrhea, consider testing for bile acid malabsorption using SeHCAT scanning or serum 7α-hydroxy-4-cholesten-3-one. 1 If confirmed, cholestyramine (bile acid sequestrant) may be effective. 1

  • Avoid codeine for diarrhea control as it is more likely to cause sedation and drug dependency compared to loperamide. 1

Psychological Therapies for Refractory Symptoms

  • When symptoms persist despite 12 months of pharmacological treatment, consider IBS-specific cognitive behavioral therapy or gut-directed hypnotherapy, both of which are effective for global symptoms and abdominal pain. 1, 3, 2, 4

Critical Pitfalls to Avoid

  • Never use opioids for chronic abdominal pain management due to risks of dependence and complications. 3

  • Do not recommend gluten-free diets unless celiac disease has been confirmed. 1, 2

  • Review treatment effectiveness after 3 months and discontinue if there is no response. 3

  • Recognize that complete symptom resolution is often not achievable; the goal is symptom relief and improved quality of life. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Irritable Bowel Syndrome with Diarrhea (IBS-D)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento del Síndrome de Intestino Irritable

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

The American journal of gastroenterology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.